FDA Warning Letter — Centaur Pharmaceuticals Private Ltd.

Case 651080 — FEI 3003973520

The FDA took a Warning Letter action against Centaur Pharmaceuticals Private Ltd. on June 5, 2023 (Thane, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Centaur Pharmaceuticals Private Ltd.
Date
June 5, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Thane (India)